Tag: Roots Analysis
Global Collaborative Robots (Cobots) Market, 2020-2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”
Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed, or are being actively adopted across various industries, including the life sciences and pharmaceutical industry, claims
The USD 18 billion (by 2030) financial opportunity within the global cobots market has been analyzed across the following segments
global collaborative robots (cobots) market is projected to grow at an annualized rate of 34.4%, till 2030
Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry; interestingly, the majority (>55%) of such service providers firms are based in Europe
The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments
The global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030, growing at a CAGR of 34.4%, claims Roots Analysis
Roots Analysis is pleased to announce the publication of its recentstudy, titled, “GlobalCollaborative Robots (Cobots) Market, 2020-2030.”
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism.
More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development
Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration.
The subcutaneous biologic drugs and affiliated technologies
Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 covering key aspects of the industry and identifying future growth opportunities.
The subcutaneous biologic drugs and affiliated technologies market
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare.
Many small / macro molecule-based STING pathway
In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community.
The STING pathway - Roots Analysis
Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.” covering key aspects of the industry and identifying future growth opportunities.
The STING pathway targeting technologies - Roots Analysis
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy.
The biopharmaceutical contract manufacturing market -Roots Analysis
Roots Analysis has done a detailed study on Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The biopharmaceutical contract manufacturing market
Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages.
Growing at an annualized rate of over 9%, the antibody discovery services market
; the antibody discovery platforms market is estimated to be worth close to USD 6 billion by 2030: Roots Analysis
